<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00801099</url>
  </required_header>
  <id_info>
    <org_study_id>SSII</org_study_id>
    <nct_id>NCT00801099</nct_id>
  </id_info>
  <brief_title>Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections</brief_title>
  <acronym>SSI2</acronym>
  <official_title>Benefit of a Single Preoperative Dose of Antibiotics in a Sub-Saharan District Hospital: Minimal Input, Massive Impact</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Tropical &amp; Public Health Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Academy of Medical Sciences (SAMS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Tropical &amp; Public Health Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a rural hospital in Tanzania the rate of surgical site infections (SSI) was 21.6%.
      Inappropriate choice of antibiotics and of administration time were determined as sole risk
      factors in this setting. After implementation of a standardized procedure with a single shot
      dose of Amoxicillin/Clavulanic Acid approximately 30 min. preoperatively the rate of SSI
      dropped by 80% in spite of procedural risk factors like poor hygiene etc.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical Site Infections (SSIs) have an important socioeconomic impact prolonging the period
      of hospitalization and rehabilitation. Patients with SSIs are five times more likely to be
      readmitted and are even twice as likely to die compared to patients with similar
      interventions without SSI. In non-industrialized countries, the incidence of SSIs is higher
      and the consequences of SSI are even more severe: Many hospitals lack appropriate facilities
      for early diagnosis and treatment. In addition, microbiological identification of pathogens
      and susceptibility testing are rarely available, a prerequisite for targeted treatment of
      SSIs. Overcrowding and understaffing are additional risk factors for SSIs, common in these
      countries.

      A study conducted at the local surgeons' suggestion in an 82-bed department of general
      surgery, obstetrics and gynecology, urology and orthopedics at the St. Francis Designated
      District Hospital (SFDDH) in Ifakara (Southern Tanzania) showed an SSI-rate of 21.6%.

      The analyses of this study identified two major risk factors for SSI in clean and
      clean-contaminated surgical procedures: Inadequate timing of administration of routine
      antimicrobial prophylaxis (AMP) and inappropriate selection of antibiotics not covering the
      most commonly observed pathogens.

      Therefore, an intervention study was discussed with the local surgeon in charge to improve
      selection and timing of routine AMP and thereby reduce the rate of SSIs.

      The study design and objective were presented to all the staff during a general meeting and
      special duties and responsibilities discussed with the individual colleagues. Furthermore we
      distributed pocket flow sheets to the involved staff and hung up some laminated flow sheets
      in theatre.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">March 2005</completion_date>
  <primary_completion_date type="Actual">March 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Surgical Site Infections</measure>
    <time_frame>within 30 days postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sustainability of the Intervention in This Setting</measure>
    <time_frame>during 3 month of study phase</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">276</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Abx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single shot dose of Amoxicillin/Clavulanic Acid approximately 30 min. preoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin/Clavulanic Acid</intervention_name>
    <description>single shot dose of Amoxicillin/Clavulanic Acid approximately 30 min. preoperatively</description>
    <arm_group_label>Abx</arm_group_label>
    <other_name>Augmentin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  surgical patient

          -  clean or clean-contaminated surgery

        Exclusion Criteria:

          -  infection

          -  preoperative antibiotic treatment

          -  postoperative antibiotic treatment

          -  open fractures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christioph F Hatz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Swiss Tropical &amp; Public Health Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Swiss Tropical Institute</name>
      <address>
        <city>Basel</city>
        <state>BS</state>
        <zip>4001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Saxer F, Widmer A, Fehr J, Soka I, Kibatala P, Urassa H, Frei R, Smith T, Hatz C. Benefit of a single preoperative dose of antibiotics in a sub-saharan district hospital: minimal input, massive impact. Ann Surg. 2009 Feb;249(2):322-6. doi: 10.1097/SLA.0b013e31819782fd.</citation>
    <PMID>19212189</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2008</study_first_submitted>
  <study_first_submitted_qc>December 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2008</study_first_posted>
  <results_first_submitted>November 6, 2008</results_first_submitted>
  <results_first_submitted_qc>December 2, 2008</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 3, 2008</results_first_posted>
  <last_update_submitted>July 16, 2015</last_update_submitted>
  <last_update_submitted_qc>July 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. med. C. Hatz</name_title>
    <organization>Department of Medicine and Diagnostics, Swiss Tropical Institute</organization>
  </responsible_party>
  <keyword>Postoperative wound infection</keyword>
  <keyword>surgical site infection</keyword>
  <keyword>antimicrobial prophylaxis</keyword>
  <keyword>developing countries</keyword>
  <keyword>Sub-Saharan Africa</keyword>
  <keyword>reduction of SSI using preoperative antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All consecutive patients older than 15 years admitted for clean or clean-contaminated (according to Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp.Epidemiol. 1999;20:250-78) interventions.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Amoxicillin/Clavulanic Acid</title>
          <description>Single shot dose of Amoxicillin/Clavulanic Acid approximately 30 minutes preoperatively.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="276"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="175"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="101"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="101"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Amoxicillin/Clavulanic Acid</title>
          <description>Single shot dose of Amoxicillin/Clavulanic Acid approximately 30 minutes preoperatively.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="276"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Tanzania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Surgical Site Infections</title>
        <time_frame>within 30 days postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Amoxicillin/Clavulanic Acid</title>
            <description>Single shot dose of Amoxicillin/Clavulanic Acid approximately 30 minutes preoperatively.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Surgical Site Infections</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sustainability of the Intervention in This Setting</title>
        <time_frame>during 3 month of study phase</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Amoxicillin/Clavulanic Acid</title>
          <description>Single shot dose of Amoxicillin/Clavulanic Acid approximately 30 minutes preoperatively.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>SSI</sub_title>
                <description>infection at surgical site</description>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="276"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Franziska Saxer, MD</name_or_title>
      <organization>Swiss Tropical Institute</organization>
      <email>franziskabrenneke@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

